Events & Presentations

Presentations
DateTitle
April 4, 2018
Download Documentation Corporate Presentation
Get help downloading or viewing the above file types
Upcoming Events
Ovid Therapeutics Inc at the American Academy of Neurology 70th Annual Meeting
Saturday, April 21, 2018 through Friday, April 27, 2018
Supporting Materials:
Download Event Supporting Material Ovid Therapeutics Announces Multiple Poster Presentations of OV101 and TAK-935/OV935 at the American Academy of Neurology 70th Annual Meeting
Add to Calendar Add Ovid Therapeutics Inc at the American Academy of Neurology 70th Annual Meeting to Calendar  Help
Event in Progress remind me
Past Events
Q4 2017 Ovid Therapeutics Inc Earnings Conference Call
Thursday, March 29, 2018 5:00 p.m. ET
Ovid Therapeutics Inc at 25th Annual Future Leaders in the Biotech Industry
Friday, March 23, 2018 10:00 a.m. ET
Ovid Therapeutics Inc at Cowen and Company 38th Annual Health Care Conference
Monday, March 12, 2018 2:10 p.m. ET
Ovid Therapeutics Inc at RBC Capital Markets 2018 Healthcare Conference
Thursday, February 22, 2018 3:05 p.m. ET
Ovid Therapeutics at Citi 2017 Global Healthcare Conference
Wednesday, December 6, 2017
Ovid Therapeutics at Oppenheimer Rare Disease Day
Tuesday, December 5, 2017
Ovid Therapeutics at American Epilepsy Society (AES) 71st Annual Meeting
Friday, December 1, 2017 through Tuesday, December 5, 2017
Description:
Supporting Materials:
Download Event Supporting Material Ovid Therapeutics Presents New Data Demonstrating Potential of TAK-935/OV935 as a Novel Treatment for Developmental and Epileptic Encephalopathies at the American Epilepsy Society (AES) Annual Meeting
Ovid Therapeutics at Evercore ISI 2017 BioPharma Catalyst/Deep Dive Conference
Thursday, November 30, 2017 12:50 p.m. ET
Ovid Therapeutics at 29th Annual Piper Jaffray Healthcare Conference
Wednesday, November 29, 2017 9:30 a.m. ET
Ovid Therapeutics at Stifel 2017 Healthcare Conference
Tuesday, November 14, 2017 8:00 a.m. ET
Ovid Therapeutics at 18th International Fragile X and Related Neurodevelopmental Disorders Workshop
Sunday, October 15, 2017 5:00 p.m. ET
Ovid Therapeutics at Citi 12th Annual Biotech Conference
Thursday, September 7, 2017
Dr. Yaron Werber, Chief Business & Financial Officer to Participate in the JMP Securities 2017 Life Sciences Conference
Tuesday, June 20, 2017 1:00 p.m. ET
Description: The Emerging Landscape of Orphan/CNS Disorders
Location: St. Regis Hotel
2 East 55th Street
New York, NY 10022
Dr. Matthew During, Founder, President and Chief Scientific Officer to present at the Antiepileptic Drug and Device Trials XIV Conference
Friday, May 19, 2017
Description: OV935/TAK935, a novel NMDA modulator under development for epileptic encephalopathies
Location: Turnberry Isle Miami Hotel
1999 W Country Club Drive
Aventura, FL
Ovid Therapeutics to Ring The Nasdaq Stock Market Closing Bell
Wednesday, May 10, 2017 4:00 p.m. ET
Location: Nasdaq MarketSite
4 Times Square
New York, NY

Investor & Media

Stockholder Tools

Investor Contact

Steve Klass
Vice President, Investor Relations
Burns McClellan, Inc.

(212) 213-0006
investors@ovidrx.com

Media Contact

Katie Engleman
Senior Media Director
Pure Communications, Inc.

(919) 333-7722
katie@purecommunicationsinc.com